Identification of Optimal Measures of Human Abuse Potential A Post Hoc Assessment of 19 StudiesJOURNAL OF CLINICAL PSYCHOPHARMACOLOGYIF2.82020-10-211PRE
Psychedelic Drugs as Therapeutics: No Illusions About the ChallengesCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52017-08-2425PREAI
Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor AntagonistJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82016-12-0129OAAI
The Effect of an Abuse-Deterrent Opioid Formulation (OxyContin) on Opioid Abuse-Related Outcomes in the Postmarketing SettingCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52016-06-2270OAAI
Abuse deterrent opiate formulations: an imperfect solution to a perfect storm?EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72014-10-010PREAI
Assessment of the Abuse Liability of a Dual Orexin Receptor Antagonist: A Crossover Study of Almorexant and Zolpidem in Recreational Drug UsersCNS DRUGSIF7.42014-03-1413PREAI
From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonistsTRENDS IN PHARMACOLOGICAL SCIENCESIF19.92013-10-0187PREAI
Explicit claims for tamper resistant and abuse deterrent opiates: FDA draft guidanceEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72013-10-010PREAI
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendationsPAINIF5.52012-12-0159OA
Differences in the In Vitro and In Vivo Pharmacokinetic Profiles of Once-Daily Modified-Release Methylphenidate Formulations in Canada: Examination of Current Bioequivalence CriteriaCLINICAL THERAPEUTICSIF3.62012-05-0117PREAI
Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug UsersCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52011-03-1659PREAI
The role of adverse events and related safety data in the pre-market evaluation of drug abuse potentialDRUG AND ALCOHOL DEPENDENCEIF3.62010-12-0110PREAI
Oral ketamine as a positive control in human abuse potential studies口服氯胺酮作为人类滥用潜力研究的阳性对照DRUG AND ALCOHOL DEPENDENCEIF3.62010-11-2423PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向